ARQT Annual EBITDA
-$227.79 M
+$67.08 M+22.75%
31 December 2023
Summary:
As of January 23, 2025, ARQT annual earnings before interest, taxes, depreciation & amortization is -$227.79 million, with the most recent change of +$67.08 million (+22.75%) on December 31, 2023. During the last 3 years, it has fallen by -$92.24 million (-68.04%). ARQT annual EBITDA is now -5447.83% below its all-time high of -$4.11 million, reached on December 31, 2017.ARQT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARQT Quarterly EBITDA
-$33.45 M
+$11.04 M+24.82%
30 September 2024
Summary:
As of January 23, 2025, ARQT quarterly earnings before interest, taxes, depreciation & amortization is -$33.45 million, with the most recent change of +$11.04 million (+24.82%) on September 30, 2024. Over the past year, it has increased by +$344.00 thousand (+1.02%). ARQT quarterly EBITDA is now -461.94% below its all-time high of -$5.95 million, reached on December 31, 2018.ARQT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARQT TTM EBITDA
-$163.28 M
+$344.00 K+0.21%
30 September 2024
Summary:
As of January 23, 2025, ARQT TTM earnings before interest, taxes, depreciation & amortization is -$163.28 million, with the most recent change of +$344.00 thousand (+0.21%) on September 30, 2024. Over the past year, it has increased by +$71.22 million (+30.37%). ARQT TTM EBITDA is now -2642.84% below its all-time high of -$5.95 million, reached on December 31, 2018.ARQT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARQT EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.8% | +1.0% | +30.4% |
| 3 y3 years | -68.0% | +1.0% | +30.4% |
| 5 y5 years | -1054.3% | +1.0% | +30.4% |
ARQT EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -10.6% | +22.8% | -22.9% | +67.4% | at high | +46.5% |
| 5 y | 5-year | -429.0% | +22.8% | -157.9% | +67.4% | -279.2% | +46.5% |
| alltime | all time | -5447.8% | +22.8% | -461.9% | +67.4% | -2642.8% | +46.5% |
Arcutis Biotherapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$33.45 M(-24.8%) | -$163.28 M(-0.2%) |
| June 2024 | - | -$44.50 M(+63.5%) | -$163.63 M(-10.3%) |
| Mar 2024 | - | -$27.22 M(-53.2%) | -$182.38 M(-20.0%) |
| Dec 2023 | -$227.79 M(-22.7%) | -$58.11 M(+71.9%) | -$227.86 M(-2.8%) |
| Sept 2023 | - | -$33.80 M(-46.6%) | -$234.50 M(-22.7%) |
| June 2023 | - | -$63.26 M(-13.0%) | -$303.24 M(-0.7%) |
| Mar 2023 | - | -$72.69 M(+12.3%) | -$305.23 M(+3.5%) |
| Dec 2022 | -$294.87 M(+43.2%) | -$64.76 M(-36.8%) | -$294.87 M(-2.1%) |
| Sept 2022 | - | -$102.53 M(+57.1%) | -$301.31 M(+17.9%) |
| June 2022 | - | -$65.25 M(+4.7%) | -$255.64 M(+10.1%) |
| Mar 2022 | - | -$62.34 M(-12.4%) | -$232.29 M(+12.8%) |
| Dec 2021 | -$205.90 M | -$71.19 M(+25.2%) | -$205.90 M(+22.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$56.86 M(+35.7%) | -$167.77 M(+12.5%) |
| June 2021 | - | -$41.90 M(+16.6%) | -$149.18 M(+4.4%) |
| Mar 2021 | - | -$35.94 M(+8.7%) | -$142.88 M(+5.4%) |
| Dec 2020 | -$135.56 M(+214.8%) | -$33.06 M(-13.6%) | -$135.56 M(+17.4%) |
| Sept 2020 | - | -$38.27 M(+7.5%) | -$115.46 M(+25.8%) |
| June 2020 | - | -$35.60 M(+24.4%) | -$91.82 M(+41.8%) |
| Mar 2020 | - | -$28.62 M(+120.7%) | -$64.76 M(+50.4%) |
| Dec 2019 | -$43.06 M(+118.2%) | -$12.97 M(-11.3%) | -$43.06 M(+19.5%) |
| Sept 2019 | - | -$14.63 M(+71.4%) | -$36.05 M(+68.3%) |
| June 2019 | - | -$8.54 M(+23.2%) | -$21.42 M(+66.3%) |
| Mar 2019 | - | -$6.93 M(+16.4%) | -$12.88 M(+116.4%) |
| Dec 2018 | -$19.73 M(+380.6%) | -$5.95 M | -$5.95 M |
| Dec 2017 | -$4.11 M | - | - |
FAQ
- What is Arcutis Biotherapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual EBITDA year-on-year change?
- What is Arcutis Biotherapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly EBITDA year-on-year change?
- What is Arcutis Biotherapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics TTM EBITDA year-on-year change?
What is Arcutis Biotherapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ARQT is -$227.79 M
What is the all time high annual EBITDA for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$4.11 M
What is Arcutis Biotherapeutics annual EBITDA year-on-year change?
Over the past year, ARQT annual earnings before interest, taxes, depreciation & amortization has changed by +$67.08 M (+22.75%)
What is Arcutis Biotherapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ARQT is -$33.45 M
What is the all time high quarterly EBITDA for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$5.95 M
What is Arcutis Biotherapeutics quarterly EBITDA year-on-year change?
Over the past year, ARQT quarterly earnings before interest, taxes, depreciation & amortization has changed by +$344.00 K (+1.02%)
What is Arcutis Biotherapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ARQT is -$163.28 M
What is the all time high TTM EBITDA for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$5.95 M
What is Arcutis Biotherapeutics TTM EBITDA year-on-year change?
Over the past year, ARQT TTM earnings before interest, taxes, depreciation & amortization has changed by +$71.22 M (+30.37%)